Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program-LynTurk study

dc.authorid0000-0002-0156-5973
dc.contributor.authorEsin, Ece
dc.contributor.authorAhmed, Melin Aydan
dc.contributor.authorYildirim, Hasan Cagri
dc.contributor.authorMandel, Nil Molinas
dc.contributor.authorErdemoglu, Engin
dc.contributor.authorSari, Murat
dc.contributor.authorAydiner, Adnan
dc.date.accessioned2025-05-10T19:27:40Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 02-06, 2023 -- Chicago, IL
dc.description.abstract[No abstract available]
dc.description.sponsorshipAmer Soc Clin Oncol
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7032
dc.identifier.volume41
dc.identifier.wosWOS:001053772003901
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleSafety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program-LynTurk study
dc.typeConference Object

Dosyalar